Biological plausibility between proton pump inhibitory therapy and hip fracture: hyperhomocysteinemia can be the link.
Roblin
Xavier
X
Phelip
Jean Marc
JM
D000368:Aged; D005260:Female; D005764:Gastroesophageal Reflux / Q000097:blood / Q000188:drug therapy; D006620:Hip Fractures / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D015994:Incidence; D008297:Male; D054328:Proton Pump Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors; D014806:Vitamin B 12 Deficiency / Q000097:blood / Q000150:complications / Q000453:epidemiology
D054328:Proton Pump Inhibitors; D006710:Homocysteine